|
|
Kangmei Pharmaceutical Co., Ltd. develops, produces, and sells pharmaceutical products intended primarily for treating hypertension and colds. The group offers Chinese medications (ginseng, salvia, codonopsis, etc.) and chemical medications (clarithromycin, doxazosin mesylate, paracetamol, etc.).
All sales are earned in China.
Number of employees : 9 209 people.
|
|
|
| 2019 | | CNY (in Million) | % | | Pharmaceutical | 9,281 | 82.7% | | Property Rental and Other | 1,825 | 16.3% | | Health Food and Food | 339.93 | 3% |
|
|
|
| 2019 | | CNY (in Million) | % | | China | 11,390 | 101.4% | | Overseas | 55.17 | 0.5% |
|
|
|
| Vote  | Quantity | Free-Float | Company-owned shares | Total Float |
| Stock A |
1 |
4,973,861,675 |
2,544,449,237 |
51.2% |
40,957,000 |
0.8% |
51.2% |
| Stock B |
0 |
30,000,000 |
0 |
0.0% |
0 |
0.0% |
|
|
|
| Name | Equities | % | | Xing Tian Ma | 1,409,018,378 |
32.0% | | Minmetals International Trust Co.,Ltd. | 231,901,482 |
5.26% | | China Securities Finance Corp. Ltd. | 148,719,122 |
3.37% | | Changzhou Yanze Yonghui Investment Center LP | 120,457,584 |
2.73% | | Dong Jin Xu | 107,793,720 |
2.45% | | Puning Jinxin Diandanghang Co. Ltd. | 93,114,716 |
2.11% | | Puning City Intl Information Consulting Service Co. L | 93,114,700 |
2.11% | | Yan Jun Xu | 69,836,056 |
1.58% | | China Asset Management Co., Ltd. | 53,226,122 |
1.21% | | Da Cheng Fund Management Co., Ltd. | 51,837,947 |
1.18% |
|
|
|
|
| - Bloomberg Code : |
|
| - Reuters Code : |
|
| - Datastream Code : |
|
|
| Company contact information |
|
Kangmei Pharmaceutical Co., Ltd. Xiameilin, Futian District 3 Taike Road CN-GD 518000 Shenzhen, Guangdong Phone : +86 0755 33187777 Fax : +86 0755 33915850 web site : http://www.kangmei.com.cn |
|
|
Sector Pharmaceuticals - NEC
Connections : Kangmei Pharmaceutical Co., Ltd. |
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
